Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease
Xin Li, Sha Fang, Yang Yu, Hongyu Yang, Yuefeng Rao, Dongsheng Hong, Chao Lü, Mengli Yu, Xiaoyang Lu, Chaohui Yu, Qingwei Zhao
Topics & Concepts
Inflammatory bowel diseaseInfliximabMedicineInflammatory Bowel DiseasesDiseaseImmunologyTumor necrosis factor alphaInternal medicineInhalation and Respiratory Drug DeliveryAdvanced Drug Delivery SystemsImmunotherapy and Immune Responses